APA (7th ed.) Citation

Yang, F., Liu, J., Gu, J., Chen, M., Huang, B., Kuang, L., & Li, J. (2025). MASS-4 is more suitable than MASS-3 for prognostic stratification in transplant-eligible patients with newly diagnosed multiple myeloma. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Yang, Fan, Junru Liu, Jingli Gu, Meilan Chen, Beihui Huang, Lifen Kuang, and Juan Li. MASS-4 Is More Suitable than MASS-3 for Prognostic Stratification in Transplant-eligible Patients with Newly Diagnosed Multiple Myeloma. Taylor & Francis Group, 2025.

MLA (9th ed.) Citation

Yang, Fan, et al. MASS-4 Is More Suitable than MASS-3 for Prognostic Stratification in Transplant-eligible Patients with Newly Diagnosed Multiple Myeloma. Taylor & Francis Group, 2025.